<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0035">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Feng</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wu</surname>
    <given-names>Z-X</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhao</surname>
    <given-names>Z</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group> (
  <year>2019</year>). 
  <article-title>Engineering of bone- and CD44-dual-targeting redox-sensitive liposomes for the treatment of orthotopic osteosarcoma</article-title>. 
  <source>ACS Appl Mater Interfaces</source>
  <volume>11</volume>:
  <fpage>7357</fpage>–
  <lpage>68</lpage>.
  <pub-id pub-id-type="pmid">30682240</pub-id>
 </mixed-citation>
</ref>
